We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
Cap. Flow
+$113M
Cap. Flow %
9.6%
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$12.6M
2
MFC icon
Manulife Financial
MFC
+$7.56M
3
GKOS icon
Glaukos
GKOS
+$7.01M
4
AMZN icon
Amazon
AMZN
+$6.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.26M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$11.7M
2
UNH icon
UnitedHealth
UNH
+$11.3M
3
IRTC icon
iRhythm Holdings
IRTC
+$9.63M
4
HALO icon
Halozyme
HALO
+$8.33M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 46.65%
2 Financials 13.97%
3 Consumer Discretionary 13.94%
4 Technology 8.36%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFC icon
26
Manulife Financial
MFC
$72.6B
$17.3M 1.46%
1,004,270
+400,000
+66% +$7.56M
KEYS icon
27
Keysight
KEYS
$60.6B
$17.2M 1.46%
124,852
-5,885
-5% -$837K
BAX icon
28
Baxter International
BAX
$13.9B
$16.8M 1.43%
262,100
+845
+0.3% +$61.3K
AAPL icon
29
Apple
AAPL
$4.41T
$16.8M 1.42%
123,034
+13,073
+12% +$1.98M
SCHW
30
Charles Schwab
SCHW
$189B
$16.3M 1.38%
258,338
-291
-0.1% -$20.1K
AXP icon
31
American Express
AXP
$232B
$15.7M 1.33%
113,172
-20,385
-15% -$3.37M
UTHR icon
32
United Therapeutics
UTHR
$21.9B
$15.6M 1.32%
66,091
+19,012
+40% +$3.87M
SWAV
33
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$14.1M 1.2%
73,854
+25,115
+52% +$4.43M
MSFT icon
34
Microsoft
MSFT
$3.66T
$14.1M 1.19%
54,955
+4,822
+10% +$1.31M
RCM
35
DELISTED
R1 RCM Inc. Common Stock
RCM
$14M 1.19%
668,797
+9,276
+1% +$210K
MDRX
36
DELISTED
Veradigm Inc. Common Stock
MDRX
$11.8M 0.99%
792,589
-56,056
-7% -$1.05M
CHE icon
37
Chemed
CHE
$7.07B
$11.7M 0.99%
25,000
– –
TNDM icon
38
Tandem Diabetes Care
TNDM
$1.63B
$11M 0.94%
186,677
-79
-0% -$6.49K
APLS
39
DELISTED
Apellis Pharmaceuticals
APLS
$8.82M 0.75%
195,126
-26,125
-12% -$1.19M
VRTS icon
40
Virtus Investment Partners
VRTS
$1.12B
$8.55M 0.72%
50,000
– –
AWK icon
41
American Water Works
AWK
$26.8B
$7.8M 0.66%
52,431
+37,759
+257% +$5.75M
SGFY
42
DELISTED
Signify Health, Inc.
SGFY
$6.93M 0.59%
502,447
-24,946
-5% -$351K
ALNY icon
43
Alnylam Pharmaceuticals
ALNY
$30B
$6.72M 0.57%
46,104
-36,934
-44% -$5.24M
GKOS icon
44
Glaukos
GKOS
$11B
$6.71M 0.57%
+147,742
New +$7.01M
RSG icon
45
Republic Services
RSG
$65.6B
$6.09M 0.52%
+46,549
New +$6.11M
HTHT icon
46
Huazhu Hotels Group
HTHT
$12.7B
$6.09M 0.52%
159,828
+13,000
+9% +$407K
IRTC icon
47
iRhythm Holdings
IRTC
$4.13B
$6.03M 0.51%
55,831
-72,687
-57% -$9.63M
GDRX icon
48
GoodRx Holdings
GDRX
$1.22B
$5.97M 0.51%
1,007,935
-185,187
-16% -$2.06M
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$4.2T
$5.8M 0.49%
+53,200
New +$6.26M
TJX icon
50
TJX Companies
TJX
$169B
$5.71M 0.48%
102,224
+69,400
+211% +$4.2M
1
2
3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review

As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
  • Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
  • Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
  • Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.